Jonathan Leiken
CIK 1608984 · View on SEC EDGAR ↗
First SEC filing: March 3, 2026 · Latest: March 3, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 1, 2025 | DLTR | S | 177 | $75.56 | $13,374 | 23,704 Direct | -0.74% | Disposed | 78.4% (price as of 2026-08-19) |
| May 12, 2022 | DBD | P | 4,400 | $2.40 | $10,560 | 269,108 Direct | +1.66% | Acquired | 2743.3% (price as of 2026-08-19) |
| July 28, 2017 | DBD | P | 2,000 | $22.97 | $45,940 | 33,985 Direct | +6.25% | Acquired | 197.1% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 4, 2026 | DHR | Employee stock option (right to buy) | Common Stock (92,138) | $194.78 | Aug. 4, 2036 | 92,138 | Acquired |
| March 1, 2026 | DHR | Employee stock option (right to buy) | Common Stock (6,416) | $210.64 | March 1, 2036 | 6,416 | Acquired |
| Feb. 2, 2026 | DHR | Danaher Deferred Compensation Programs - Danaher Stock Fund [F1] | Common Stock (41) | — | — | 41 | Acquired |
| Nov. 15, 2025 | DHR | Employee stock option (right to buy) | Common Stock (26,767) | $221.21 | Nov. 15, 2035 | 26,767 | Acquired |
| April 1, 2024 | DLTR | Stock Option (right to buy) | Common Stock (5,406) | $135.91 | — | 5,406 | Acquired |
| Oct. 27, 2023 | DLTR | Stock Option (right to buy) | Common Stock (2,697) | $108.24 | — | 2,697 | Acquired |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (12,048) | $11.96 | Jan. 30, 2030 | 12,048 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (43,715) | $4.08 | Jan. 29, 2029 | 43,715 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F3] | Common Shares (24,517) | $18.75 | Feb. 1, 2028 | 24,517 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F2] | Common Shares (46,875) | $26.60 | Feb. 8, 2027 | 46,875 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F2] | Common Shares (24,581) | $27.39 | Feb. 3, 2026 | 24,581 | Disposed |
| Aug. 11, 2023 | DBD | Non-Qualified Stock Option [F2] | Common Shares (21,397) | $32.33 | Feb. 5, 2025 | 21,397 | Disposed |
| Jan. 30, 2020 | DBD | Non-Qualified Stock Option [F5] | Common Shares (12,048) | $11.96 | Jan. 30, 2030 | 12,048 | Acquired |
| Jan. 29, 2019 | DBD | Non-Qualified Stock Option [F4] | Common Shares (43,715) | $4.08 | Jan. 29, 2029 | 43,715 | Acquired |
| Feb. 1, 2018 | DBD | Non-Qualified Stock Option [F1,F2] | Common Shares (24,517) | $18.75 | Feb. 1, 2028 | 24,517 | Acquired |
| Feb. 1, 2018 | DBD | Common Shares [F4] | Common Shares (35,975) | $18.75 | Feb. 1, 2028 | 35,975 | Acquired |
| Feb. 8, 2017 | DBD | Non-Qualified Stock Options [F3] | Common Shares (46,875) | $26.60 | Feb. 7, 2027 | 46,875 | Acquired |
| Feb. 3, 2016 | DBD | Non-Qualified Stock Option [F3] | Common Shares (24,581) | $27.39 | Feb. 3, 2026 | 24,581 | Acquired |
| Feb. 5, 2015 | DBD | Non-Qualified Stock Option [F3] | Common Shares (21,397) | $32.33 | Feb. 5, 2025 | 21,397 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 27, 2025 | DHR | No securities are beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
Chief Legal Officer and Corporate Secretary| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | — | — | — | — | — | — | $30,714 | $1,916,325 |
| 2021 | — | — | — | — | $660,336 | — | $23,704 | $2,062,508 |
| 2020 | — | — | — | — | $380,205 | — | $23,466 | $1,313,192 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.